Skip to main content
. 1998 May;66(5):2143–2153. doi: 10.1128/iai.66.5.2143-2153.1998

TABLE 2.

Protection of mice by active immunization with different forms of DbpA compared with that by immunization with OspA

Expt (mouse strain/challenge isolate) Mouse group Immunogena No. of positive cultures/total no. tested
P39 IgGb No. of mice infected/total no.
Bladder Ear Joint
A (C3H/297) 1 His-DbpA297 0/5 0/5 0/5 0/5 0/5
2 Lpp1:DbpA297 0/5 0/5 0/5 0/5 0/5
3 OspAB31 0/5 0/5 0/5 0/5
4 PBS 5/5 5/5 4/5 + 5/5
B (C3H/N40) 1 Lpp2:DbpAN40His 0/5 0/5 0/5 0/5 0/5
2 OspAB31 5/5 0/5 0/5 + 5/5
3 E. coli BL21 (det.) 4/4 4/4 1/4 + 4/4c
4 None 5/5 5/5 5/5 + 5/5
Cd (BALB/B31) 1 Pre-DbpA297 0/5 0/5 0/5 0/5 0/5
2 OspAB31 0/5 0/5 0/5 0/5
3 E. coli JM101 (sol.) 5/5 5/5 5/5 ND 5/5
4 None 5/5 5/5 5/5 + 5/5
(C3H/B31) 5 Pre-DbpA297 5/5 0/5 0/5 5/5 5/5
6 OspAB31 0/5 0/5 0/5 0/5
7 E. coli JM101 (sol.) 5/5 5/5 5/5 ND 5/5
8 None 5/5 5/5 5/5 + 5/5
D (C3H/B31) 1 Pre-DbpA297 5/5 0/5 0/5 5/5 5/5
2 Lpp1:DbpA297 5/5 0/5 0/5 5/5 5/5
3 OspAB31 0/5 0/5 0/5 0/5
4 E. coli JM101 (sol.) 5/5 5/5 5/5 + 5/5
5 E. coli BL21 (det.) 5/5 5/5 5/5 + 5/5
6 None 5/5 5/5 5/5 + 5/5
Ed (C3H/B31) 1 Pre-DbpA297 3/5 0/5 0/5 3/5 3/5
2 His-DbpA297 1/5 0/5 1/5 1/5 1/5
3 His-DbpAB31 1/4 0/4 0/4 0/4 1/4c
4 OspAB31 0/5 0/5 0/5 0/5 0/5
5 E. coli M15 (sol.) 5/5 5/5 5/5 ND 5/5
6 None 5/5 5/5 5/5 5/5 5/5
a

Immunogen doses were 20 μg for DbpA, 5 μg for OspA, and 5 μg for E. coli soluble (sol.) and detergent (det.) extracts, except 20 μg in experiment C. 

b

Presence of IgG to P39 at the time of sacrifice was determined for most groups of mice (number positive/number tested). When sera were assayed as pools, the presence or absence of P39 IgG was scored as + or −, respectively. ND, not determined. 

c

Data were not recorded for one mouse in groups B3 and E3 that died prior to challenge. 

d

Data for experiments C and E are reproduced from Vaccines ’97 (10a) with permission of the publisher.